Two-Day ASHG Virtual Symposium Showcases AI-Driven and Multi-Omic Advances in Cardiovascular Science - ASHG

Two-Day ASHG Virtual Symposium Showcases AI-Driven and Multi-Omic Advances in Cardiovascular Science

For Immediate Release: Thursday, April 9, 2026, 10:00 am U.S. Eastern Time

Media Contact: Evelyn Mantegani, [email protected]

Virtual Event Highlights the Latest Research at the Intersection of Omics, Regulatory Genomics, and Artificial Intelligence

Rockville, Md. – The American Society of Human Genetics (ASHG) will host a two-day virtual symposium on April 28-29, bringing together leading researchers who are redefining how cardiovascular disease is understood, predicted, and treated.

“Omics, Regulation & AI for Precision Cardiovascular Medicine” will showcase the newest discoveries across multi-omic profiling, cardiometabolic genetics, functional genomics, and AI-driven cardiovascular prediction. Attendees who join the live sessions will be eligible to obtain 6 CME credits. By uniting experts in integrative omics and machine learning, the event highlights how advanced data-driven approaches are accelerating the future of precision cardiovascular medicine.

“Our goal when selecting these talks was to curate truly cross‑disciplinary perspectives—from basic genomics to computational modeling—that reflect the increasingly integrated nature of cardiovascular research,” said Elisha Roberson, PhD, Chair, ASHG Digital Learning Committee. “By removing geographic barriers, this virtual symposium enables researchers and clinicians at all career stages to stay current with major advances, connect with leaders across disciplines, and engage with the ideas shaping the next generation of precision cardiovascular care.”

Both days will be headlined by keynote addresses from two recognized leaders in human genetics and genomics cardiology research: ASHG Past President Bruce D. Gelb, MD, whose focus is pediatric cardiology at the Icahn School of Medicine at Mount Sinai, and Barry J. Byrne, MD, PhD, Associate Chair of Pediatrics and Director of the Powell Gene Therapy Center at the University of Florida. In addition to these keynote sessions, the program will feature twelve 30‑minute scientific talks over the course of two days highlighting the latest advances across the field.

Designed for broad participation, the online format ensures global access to leading voices while preserving robust opportunities for engagement through live discussions and Q&A.

Registration and additional event details are available on the ASHG Learning Center.

* * *

About the American Society of Human Genetics (ASHG)

The American Society of Human Genetics (ASHG) is the leading global organization advancing the science of human genetics and genomics. Representing nearly 8,000 researchers, clinicians, genetic counselors, educators, and other professionals, ASHG drives progress in understanding the human genome and its role in health and disease. The Society fosters innovation and collaboration through its flagship events and publications—including the ASHG Annual Meeting and its peer-reviewed journals The American Journal of Human Genetics and Human Genetics and Genomics Advances. ASHG also champions science advocacy, supports the next generation of genetics professionals, and promotes responsible policies and public engagement in genetics. Learn more at www.ashg.org.

6120 Executive Blvd, Suite 500 | Rockville, MD 20852 | 301.634.7300 | [email protected] | www.ashg.org
Connect with ASHG on Twitter (@GeneticsSociety) | Facebook | LinkedIn